Strategic Investment Advisors Stryker Corp Transaction History

Strategic Investment Advisors

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$194.09 - $276.37 $182,832 - $260,340	-942 Closed	0 $0
Q1 2022 Apr 28, 2022	BUY	$245.33 - $277.77 $5,887 - $6,666	24 Added 2.61%	942 $252,000
Q4 2021 Jan 26, 2022	BUY	$236.63 - $276.44 $217,226 - $253,771	918 New	918 $246,000
Q1 2020 Apr 13, 2020	SELL	$126.5 - $225.1 $197,719 - $351,831	-1,563 Closed	0 $0
Q4 2019 Jan 23, 2020	BUY	$197.98 - $220.53 $31,676 - $35,284	160 Added 11.4%	1,563 $328,000
Q3 2019 Oct 25, 2019	BUY	$205.4 - $221.82 $17,459 - $18,854	85 Added 6.45%	1,403 $303,000
Q2 2019 Jul 23, 2019	BUY	$180.24 - $205.58 $29,198 - $33,303	162 Added 14.01%	1,318 $270,000
Q1 2019 Apr 30, 2019	BUY	$152.46 - $198.0 $176,243 - $228,888	1,156 New	1,156 $228,000

2,228

285M

1.35M

1.6M

Ticker SYK
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 378,320,992
Market Cap $146B
Description
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...

Get notified when there are updates to the investment portfolio of Strategic Investment Advisors , based on Form 13F filings with the SEC.

Stay updated on Strategic Investment Advisors with notifications on news.